富士莱：与恒瑞医药合作的原料药项目有艾瑞昔布、甲磺酸阿帕替尼

Group 1 - The core point of the article is that Fujifilm (富士莱) has announced its collaboration with Hengrui Medicine (恒瑞医药) on an active pharmaceutical ingredient (API) project, which includes Eribulin and Apatinib Mesylate [1] Group 2 - The collaboration focuses on the development of specific APIs, indicating a strategic partnership in the pharmaceutical sector [1] - The mention of Eribulin and Apatinib Mesylate highlights the company's involvement in oncology-related drug development [1]